Published in Am J Gastroenterol on March 01, 2007
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09
Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med (2010) 2.90
Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs, aspirin, clopidogrel, and warfarin. J Gastroenterol (2015) 2.03
Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Arthritis Res Ther (2007) 1.51
Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol (2008) 1.49
Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J Gastroenterol (2009) 1.10
Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol (2008) 1.04
Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database. Eur J Clin Pharmacol (2012) 1.03
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol (2013) 0.99
Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. World J Gastroenterol (2013) 0.97
A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury. J Gastroenterol (2013) 0.95
Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes. Front Pharmacol (2010) 0.91
The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy. J Gastroenterol (2009) 0.91
Personalized approaches to clopidogrel therapy: are we there yet? Stroke (2010) 0.90
Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies. Drug Healthc Patient Saf (2015) 0.89
A prospective study of aspirin use and the risk of gastrointestinal bleeding in men. PLoS One (2010) 0.88
Interaction between clopidogrel and proton-pump inhibitors and management strategies in patients with cardiovascular diseases. Drug Healthc Patient Saf (2010) 0.88
The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage. Arthritis Res Ther (2013) 0.86
Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs. Oman Med J (2011) 0.86
Long-Term Outcomes of NSAID-Induced Small Intestinal Injury Assessed by Capsule Endoscopy in Korea: A Nationwide Multicenter Retrospective Study. Gut Liver (2015) 0.86
Mesotherapy versus Systemic Therapy in the Treatment of Acute Low Back Pain: A Randomized Trial. Evid Based Complement Alternat Med (2010) 0.86
Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. World J Gastroenterol (2015) 0.85
Role of nitric oxide in the gastrointestinal tract. Arthritis Res Ther (2008) 0.84
Managing adverse effects and drug-drug interactions of antiplatelet agents. Nat Rev Cardiol (2011) 0.84
Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk. Pain Pract (2013) 0.84
Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance. Ther Adv Chronic Dis (2013) 0.80
Impact of discontinuing non-steroidal antiinflammatory drugs on long-term recurrence in colonic diverticular bleeding. World J Gastroenterol (2015) 0.80
Efficacy of celecoxib for acute pain management following total hip arthroplasty in elderly patients: A prospective, randomized, placebo-control trial. Exp Ther Med (2015) 0.79
PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis. PLoS One (2015) 0.79
Mast cells are critical for protection against peptic ulcers induced by the NSAID piroxicam. PLoS One (2011) 0.78
Treatment and chemoprevention of NSAID-associated gastrointestinal complications. Ther Clin Risk Manag (2009) 0.78
Antiplatelet agents and proton pump inhibitors - personalizing treatment. Pharmgenomics Pers Med (2010) 0.77
The use of H2 antagonists in treating and preventing NSAID-induced mucosal damage. Arthritis Res Ther (2013) 0.76
Management of low-dose aspirin and clopidogrel in clinical practice: a gastrointestinal perspective. J Gastroenterol (2015) 0.76
Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial. Am J Gastroenterol (2016) 0.75
Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin. Drug Healthc Patient Saf (2010) 0.75
Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding. Gastroenterology (2016) 0.75
Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study. PLoS One (2016) 0.75
One fifth of hospitalizations for peptic ulcer-related bleeding are potentially preventable. World J Gastroenterol (2014) 0.75
Differences in Managing Anticoagulants and Antiplatelets for Gastrointestinal Endoscopy between East and West. Gastroenterology Res (2009) 0.75
Therapeutic potential of hydrazones as anti-inflammatory agents. Int J Med Chem (2014) 0.75
Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug Users. Medicine (Baltimore) (2015) 0.75
Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers. Drug Des Devel Ther (2015) 0.75
Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes. Patient Relat Outcome Meas (2010) 0.75
Development of NSAIDs prescription indicators based on health outcomes. Eur J Clin Pharmacol (2007) 0.75
Effect of a Proton Pump Inhibitor on Tumor Bleeding Prevention in Unresectable Gastric Cancer Patients: a Double-Blind, Randomized, Placebo-Controlled Trial. J Gastric Cancer (2017) 0.75
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med (2012) 7.18
Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology (2013) 2.85
A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol (2005) 2.60
Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol (2009) 2.53
Accuracy of GastroPanel for the diagnosis of atrophic gastritis. Eur J Gastroenterol Hepatol (2014) 2.49
Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening. J Crohns Colitis (2012) 2.21
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer (2008) 2.08
[Current management of nonvariceal upper gastrointestinal bleeding in Spain]. Gastroenterol Hepatol (2012) 2.04
Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology (2002) 2.04
Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol (2007) 1.92
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes (2009) 1.90
Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population. Circulation (2004) 1.87
Role of magnetic resonance cholangiopancreatography in patients with suspected choledocholithiasis. Mayo Clin Proc (2002) 1.84
Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol (2004) 1.81
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice. Gut (2013) 1.79
5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. Gastroenterology (2010) 1.71
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis (2012) 1.71
A method for detecting epistasis in genome-wide studies using case-control multi-locus association analysis. BMC Genomics (2008) 1.64
Risk of cancer in cases of suspected lynch syndrome without germline mutation. Gastroenterology (2013) 1.55
Oncogenicity of the developmental transcription factor Sox9. Cancer Res (2012) 1.55
Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol (2010) 1.51
Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol (2008) 1.49
Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review. Am J Gastroenterol (2008) 1.49
Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. J Natl Cancer Inst (2013) 1.47
[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference]. Med Clin (Barc) (2005) 1.47
Effectiveness of adalimumab in perianal fistulas in crohn's disease patients naive to anti-TNF therapy. J Clin Gastroenterol (2015) 1.45
Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause (2006) 1.43
[Common errors in the management of outpatients with inflammatory bowel disease]. Gastroenterol Hepatol (2007) 1.41
Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology (2012) 1.38
[Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients]. Med Clin (Barc) (2005) 1.38
Genetic structure of the Spanish population. BMC Genomics (2010) 1.34
Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network. Pharmacoepidemiol Drug Saf (2012) 1.34
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study). Scand J Gastroenterol (2010) 1.33
Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry (2008) 1.31
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients. Inflamm Bowel Dis (2013) 1.31
Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol (2012) 1.28
Malignant colorectal polyps. World J Gastroenterol (2010) 1.27
A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS One (2012) 1.24
Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol (2009) 1.23
Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations. Am J Gastroenterol (2006) 1.22
Mouse models of pancreatic cancer. World J Gastroenterol (2012) 1.20
Drug consumption and the risk of microscopic colitis. Am J Gastroenterol (2006) 1.19
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol (2003) 1.17
Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies. Gastrointest Endosc (2012) 1.15
An entropy test for single-locus genetic association analysis. BMC Genet (2010) 1.15
Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl (2002) 1.14
A short review of malabsorption and anemia. World J Gastroenterol (2009) 1.11
Gastric endoscopic submucosal dissection assisted by a new traction method: the clip-band technique. A feasibility study in a porcine model (with video). Gastrointest Endosc (2011) 1.11
Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.11
Epigenetic regulation of autophagy by the methyltransferase G9a. Mol Cell Biol (2013) 1.10
Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med (2005) 1.08
Intestinal spirochetosis and chronic watery diarrhea: clinical and histological response to treatment and long-term follow up. J Gastroenterol Hepatol (2006) 1.08
Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study. Inflamm Bowel Dis (2010) 1.06
'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures. Helicobacter (2003) 1.06
Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Am J Gastroenterol (2007) 1.05
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Helicobacter (2004) 1.05
Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol (2006) 1.04
NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies. PLoS One (2011) 1.04
Littoral-cell angioma of the spleen: a case report. World J Gastroenterol (2007) 1.03
CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model. J Alzheimers Dis (2010) 1.03
Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database. Eur J Clin Pharmacol (2012) 1.03
Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis. Eur J Gastroenterol Hepatol (2005) 1.02
GOLPH2 gene markers are not associated with Alzheimer's disease in a sample of the Spanish population. J Alzheimers Dis (2009) 1.02
Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients. Hum Immunol (2009) 1.01
MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer. Clin Cancer Res (2010) 1.01
Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals. Gastrointest Endosc (2013) 1.00
Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer. Drug Metab Rev (2012) 1.00
Ileal carcinoid tumor as a cause of massive lower-GI bleeding: the role of capsule endoscopy. Gastrointest Endosc (2004) 0.98
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib. Hepatology (2013) 0.98
The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease. Genome Med (2011) 0.98
Cytomegalovirus hepatitis and myopericarditis. World J Gastroenterol (2007) 0.98
Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. Dig Dis Sci (2002) 0.98
Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome. Ann Surg Oncol (2013) 0.97
High smoking cessation rate in Crohn's disease patients after physician advice--the TABACROHN Study. J Crohns Colitis (2012) 0.97
Adjuvant and neoadjuvant treatment in pancreatic cancer. World J Gastroenterol (2012) 0.96
Effects of resveratrol on obesity-related inflammation markers in adipose tissue of genetically obese rats. Nutrition (2013) 0.96
Crohn's disease: a review of current treatment with a focus on biologics. Drugs (2007) 0.96
Use of non-steroidal antiinflammatory drugs and type-specific risk of acute coronary syndrome. Am J Cardiol (2010) 0.96
Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am J Gastroenterol (2011) 0.96
Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment. Clin Nutr (2006) 0.96
Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol (2011) 0.96
Paucicellular lymphocytic colitis: is it a minor form of lymphocytic colitis? A clinical pathological and immunological study. Am J Gastroenterol (2009) 0.95
Anastrozole-induced hepatotoxicity. Eur J Gastroenterol Hepatol (2006) 0.95
Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am J Gastroenterol (2008) 0.94